Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Geron Corporation
Geron Corp is a biopharmaceutical company. It supports the clinical stage development of a telomerase inhibitor, imetelstat.
IPO Date: July 31, 1996
Sector: Healthcare
Industry: Biotech
Market Cap: $859.83M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.11 | 2.88%
Avg Daily Range (30 D): $0.06 | 3.83%
Avg Daily Range (90 D): $0.07 | 3.12%
Institutional Daily Volume
Avg Daily Volume: 2.69M
Avg Daily Volume (30 D): 11.77M
Avg Daily Volume (90 D): 12.91M
Trade Size
Avg Trade Size (Sh.): 342
Avg Trade Size (Sh.) (30 D): 584
Avg Trade Size (Sh.) (90 D): 532
Institutional Trades
Total Inst.Trades: 2,549
Avg Inst. Trade: $1.89M
Avg Inst. Trade (30 D): $1.55M
Avg Inst. Trade (90 D): $2.16M
Avg Inst. Trade Volume: .6M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $2.42M
Avg Closing Trade (30 D): $1.65M
Avg Closing Trade (90 D): $2.48M
Avg Closing Volume: 805.29K
       
News
Apr 29, 2025 @ 2:00 PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investo...
Source: N/A
Apr 29, 2025 @ 1:00 AM
Bragar Eagel & Squire, P.C. Reminds Investors That...
Source: N/A
Apr 28, 2025 @ 10:50 PM
Geron Corporation Investors: Please contact the Po...
Source: N/A
Apr 27, 2025 @ 8:14 PM
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Canopy ...
Source: N/A
Apr 24, 2025 @ 5:49 PM
ROSEN, A LEADING NATIONAL FIRM, Encourages Geron C...
Source: N/A
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-.27 $-.04 $-.27
Diluted EPS $-.27 $-.04 $-.27
Revenue $ 76.99M $ 47.54M $ 76.99M
Gross Profit $ $ $
Net Income / Loss $ -174.57M $ -25.35M $ -174.57M
Operating Income / Loss $ -173.73M $ -20.05M $ -173.73M
Cost of Revenue $ $ $
Net Cash Flow $ 9.75M $ 18.71M $ 9.75M
PE Ratio